Press "Enter" to skip to content

Sun Pharma To Make Eli Lilly’s Covid Medicine In India; Shares Gain

Baricitinib is used in combination with remdesivir for treatment of COVID-19 in hospitalized adults. Shares of the country’s leading drug maker Sun Pharmaceutical Industries rose as much as 3.51 per cent to hit an intraday high of ₹ 703.40 on the BSE after it signed an agreement with Eli Lilly to manufacture its drug, baricitinib in India. "Sun Pharma today announced that it has entered into a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company for expanding access to Lilly’s drug, baricitinib in India. Sun Pharma will manufacture and distribute the drug in India," Sun Pharma said […]

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *